Literature DB >> 28032911

Alanine substitutions in the GXXXG motif alter C99 cleavage by γ-secretase but not its dimerization.

Hidekazu Higashide1, Seiko Ishihara2, Mika Nobuhara2, Yasuo Ihara1, Satoru Funamoto2.   

Abstract

The amyloid β (Aβ) protein is a major component of senile plaques, one of the neuropathological hallmarks of Alzheimer's disease. Amyloidogenic processing of amyloid precursor protein (APP) by β- and γ-secretases leads to production of Aβ. APP contains tandem triple repeats of the GXXXG motif in its extracellular juxtamembrane and transmembrane regions. It is reported that the GXXXG motif is related to protein-protein interactions, but it remains controversial whether the GXXXG motif in APP is involved in substrate dimerization and whether dimerization affects γ-secretase-dependent cleavage. Therefore, the relationship between the GXXXG motifs, substrate dimerization, and γ-secretase-dependent cleavage sites remains unclear. Here, we applied blue native poly acrylamide gel electrophoresis to examine the effect of alanine substitutions within the GXXXG motifs of APP carboxyl terminal fragment (C99) on its dimerization and Aβ production. Surprisingly, alanine substitutions in the motif failed to alter C99 dimerization in detergent soluble state. Cell-based and solubilized γ-secretase assays demonstrated that increasing alanine substitutions in the motif tended to decrease long Aβ species such as Aβ42 and Aβ43 and to increase in short Aβ species concomitantly. Our data suggest that the GXXXG motif is crucial for Aβ production, but not for C99 dimerization.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer disease; amyloid-β; dimerization; enzyme processing; gamma-secretase; transmembrane domain

Mesh:

Substances:

Year:  2017        PMID: 28032911     DOI: 10.1111/jnc.13942

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase Cleavage.

Authors:  Alexander Götz; Nadine Mylonas; Philipp Högel; Mara Silber; Hannes Heinel; Simon Menig; Alexander Vogel; Hannes Feyrer; Daniel Huster; Burkhard Luy; Dieter Langosch; Christina Scharnagl; Claudia Muhle-Goll; Frits Kamp; Harald Steiner
Journal:  Biophys J       Date:  2019-05-03       Impact factor: 4.033

2.  Bicelles Rich in both Sphingolipids and Cholesterol and Their Use in Studies of Membrane Proteins.

Authors:  James M Hutchison; Kuo-Chih Shih; Holger A Scheidt; Sarah M Fantin; Kristine F Parson; George A Pantelopulos; Haley R Harrington; Kathleen F Mittendorf; Shuo Qian; Richard A Stein; Scott E Collier; Melissa G Chambers; John Katsaras; Markus W Voehler; Brandon T Ruotolo; Daniel Huster; Robert L McFeeters; John E Straub; Mu-Ping Nieh; Charles R Sanders
Journal:  J Am Chem Soc       Date:  2020-07-08       Impact factor: 15.419

3.  Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the γ-secretase cleavage sites.

Authors:  Yan Yan; Ting-Hai Xu; Kaleeckal G Harikumar; Laurence J Miller; Karsten Melcher; H Eric Xu
Journal:  J Biol Chem       Date:  2017-08-08       Impact factor: 5.157

4.  Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.

Authors:  Lei Liu; Bianca M Lauro; Michael S Wolfe; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2021-02-08       Impact factor: 5.157

5.  Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerization.

Authors:  Vanessa F Langness; Rik van der Kant; Utpal Das; Louie Wang; Rodrigo Dos Santos Chaves; Lawrence S B Goldstein
Journal:  Mol Biol Cell       Date:  2020-12-09       Impact factor: 4.138

6.  Dissecting conformational changes in APP's transmembrane domain linked to ε-efficiency in familial Alzheimer's disease.

Authors:  Alexander Götz; Christina Scharnagl
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.